StonvexLoading…
StonvexStonvexStonvexCore line items from DRD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | ZAR 7.88B | ZAR 6.24B | ZAR 5.50B | ZAR 5.12B |
Operating Income | ZAR 2.92B | ZAR 1.61B | ZAR 1.42B | ZAR 1.31B |
Net Income | ZAR 2.24B | ZAR 1.33B | ZAR 1.28B | ZAR 1.12B |
EPS (Diluted) | ZAR 2.59 | ZAR 1.53 | ZAR 1.48 | ZAR 1.31 |
Total Assets | ZAR 12.25B | ZAR 9.45B | ZAR 8.15B | ZAR 7.08B |
Total Liabilities | ZAR 3.36B | ZAR 2.56B | ZAR 1.88B | ZAR 1.64B |
Cash & Equivalents | ZAR 1.31B | ZAR 521.50M | ZAR 2.47B | ZAR 2.53B |
Free Cash Flow OCF − CapEx | ZAR 1.26B | ZAR -1.14B | ZAR 510.40M | ZAR 913.70M |
Shares Outstanding | Not available | Not available | Not available | Not available |